.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Cerilliant
Accenture
McKesson
Queensland Health
Federal Trade Commission
Boehringer Ingelheim
Merck
Teva

Generated: November 23, 2017

DrugPatentWatch Database Preview

PROBUPHINE Drug Profile

« Back to Dashboard

What is the patent landscape for Probuphine, and what generic Probuphine alternatives are available?

Probuphine is a drug marketed by Braeburn Pharms Inc and is included in one NDA. There is one patent protecting this drug.

This drug has ten patent family members in seven countries.

The generic ingredient in PROBUPHINE is buprenorphine hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.

Pharmacology for PROBUPHINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braeburn Pharms Inc
PROBUPHINE
buprenorphine hydrochloride
IMPLANT;IMPLANTATION204442-001May 26, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Braeburn Pharms Inc
PROBUPHINE
buprenorphine hydrochloride
IMPLANT;IMPLANTATION204442-001May 26, 2016RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROBUPHINE

Country Document Number Estimated Expiration
Japan4668611► Subscribe
New Zealand536965► Subscribe
European Patent Office2561860► Subscribe
MexicoPA04011875► Subscribe
Japan2005528422► Subscribe
Australia2008212011► Subscribe
Australia2003240493► Subscribe
European Patent Office1509182► Subscribe
World Intellectual Property Organization (WIPO)03101358► Subscribe
Canada2487577► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
UBS
Teva
Merck
Deloitte
Healthtrust
Baxter
US Army
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot